earli
refer
viral
ill
found
ancient
egyptian
text
stone
tablet
depict
patient
suffer
poliomyel
despit
earli
experiment
viral
infect
led
jenner
begin
later
contribut
pasteur
earli
virus
distinct
biolog
entiti
howev
discov
ivanovski
identifi
nonbacteri
pathogen
affect
tobacco
plant
subsequ
work
beijerink
loeffler
frosch
distinguish
tobacco
mosaic
diseas
footandmouth
diseas
agent
pathogen
bacteria
record
oblig
parasit
natur
first
record
human
ill
confirm
viral
origin
yellow
fever
discoveri
made
reed
et
al
sinc
larg
number
viral
pathogen
identifi
review
attempt
exhaust
deal
common
viral
ill
necessit
icu
admiss
despit
remain
notabl
exclus
includ
arbovirus
includ
caus
viral
haemorrhag
fever
zoonot
virus
includ
rabi
hepat
virus
could
constitut
review
articl
case
rare
virus
caus
icu
admiss
patient
immunocompromis
earli
involv
medic
virologist
medic
microbiologist
requir
virus
import
characterist
regard
basic
structur
small
nm
consist
genet
materi
dna
rna
contain
within
capsid
coat
made
number
viral
protein
molecul
call
capsom
fig
complet
unit
genet
materi
capsid
call
nucleocapsid
often
distinct
symmetri
depend
upon
individu
capsom
assembl
symmetri
either
icosahedr
helic
complex
virus
consist
nucleocapsid
wherea
other
outer
envelop
consist
lipid
bilay
host
cell
origin
viral
protein
glycoprotein
anchor
virus
without
membran
term
nonenvelop
nake
viral
protein
molecul
capsid
envelop
serv
three
main
function
protect
viral
rna
dna
genom
ii
possess
specif
site
allow
attach
host
cell
iii
deliveri
viral
genom
interior
infect
cell
icosahedr
capsid
capsom
arrang
tight
triangular
shape
fit
togeth
form
icosahedron
rna
virus
ssrna
genom
though
major
except
includ
reoviru
birnaviru
genom
doubl
strand
viral
ill
increasingli
recogn
caus
major
morbid
mortal
intens
care
unit
recent
viral
diseas
outbreak
indic
work
knowledg
common
pathogen
diagnosi
manag
necessari
work
intens
care
immunocompromis
patient
increas
risk
develop
overwhelm
viral
ill
earli
recognit
diagnosi
treatment
key
success
outcom
earli
involv
medic
virologist
medic
microbiologist
advis
investig
diagnosi
treatment
suspect
viral
ill
ssrna
viral
genom
posit
strand
neg
strand
strand
rna
genom
translat
protein
host
cell
similar
fashion
messeng
rna
mrna
wherea
strand
rna
genom
must
first
copi
posit
rna
strand
rnadepend
rna
polymeras
ss
rna
genom
retrovirus
first
convert
doublestrand
dna
copi
uniqu
viral
enzym
call
revers
transcriptas
transcrib
mrna
translat
protein
use
viral
replic
dna
directli
translat
protein
must
first
undergo
transcript
mrna
viral
dna
genom
usual
doublestrand
except
parvovirus
tabl
famili
share
abil
bind
glycoprotein
receptor
upper
respiratori
tract
urt
famili
includ
influenza
virus
b
c
pleomorph
virus
spheric
filament
morpholog
ssrna
segment
assembl
protein
form
helic
nucleocapsid
envelop
two
type
long
glycoprotein
spike
one
type
haemagglutinin
activ
ha
one
type
neuraminidas
activ
na
ha
spike
attach
sialic
acid
receptor
epitheli
cell
urt
provid
cellular
entri
rout
pathogen
sialic
receptor
also
exist
erythrocyt
virus
caus
agglutin
red
cell
isol
grown
cell
cultur
neuram
acid
form
part
host
mucin
defenc
barrier
neuraminidas
viral
envelop
cleav
termin
sialic
acid
group
glycoconjug
enzymat
activ
promot
entri
releas
viru
infect
cell
three
type
influenza
b
c
mani
strain
character
antigen
differ
ha
na
type
virus
infect
transmit
across
broad
host
rang
human
mammal
bird
wherea
type
b
c
appear
capabl
animaltoanim
animaltohuman
transmiss
type
caus
worldwid
pandem
wherea
type
b
c
tend
produc
local
outbreak
milder
form
antigen
drift
minor
chang
na
ha
glycoprotein
account
epidem
antigen
drift
tend
lead
less
sever
diseas
individu
preexpos
anteced
viru
major
chang
ha
call
antigen
shift
acquisit
new
gene
segment
result
pandem
sever
influenza
occur
genet
reassort
cell
dualli
infect
human
anim
viru
henc
occur
influenza
type
influenza
viru
infect
present
nonspecif
fever
myalgia
arthralgia
headach
cough
elderli
individu
chronic
diseas
eg
respiratori
renal
liver
cardiovascular
diseas
diabet
mellitu
pregnant
women
morbidli
obes
immunocompromis
higher
risk
develop
complic
infect
increas
likelihood
develop
secondari
bacteri
pneumonia
particularli
staphylococcu
aureu
pneumonia
recent
pandem
due
strain
influenza
pandem
occur
recent
outbreak
mainli
affect
yr
old
obes
pregnant
women
also
particular
risk
mani
older
patient
aliv
previou
pandem
appear
benefit
presenc
crossreact
antibodi
current
monitor
newer
avian
flu
strain
ongo
though
sustain
humantohuman
transmiss
detect
sourc
human
infect
unknown
presum
exposur
infect
bird
detect
viral
rna
revers
transcript
follow
pcr
rt
pcr
gold
standard
diagnost
method
detect
influenza
virus
carri
nose
throat
swab
nasopharyng
tracheal
aspir
bronchial
wash
highest
sensit
rtpcr
urt
specimen
within
day
onset
symptom
usual
remain
posit
patient
ongo
urt
symptom
howev
test
urt
specimen
give
fals
neg
result
patient
establish
viral
pneumonia
patient
usual
lower
respiratori
tract
lrt
sampl
posit
viru
bal
recommend
clinic
suspicion
remain
high
treatment
intens
care
larg
focus
around
organ
support
specif
therapi
includ
neuraminidas
inhibitor
oseltamivir
zanamivir
influenza
strain
sensit
therapi
resist
strain
begin
emerg
current
uk
guidanc
state
patient
complic
influenza
infect
receiv
antivir
treatment
antivir
treatment
commenc
earli
possibl
given
clinic
suspicion
irrespect
onset
ill
laboratori
confirm
influenza
viru
infect
oseltamivir
use
immunocompet
patient
evid
use
reduct
symptom
diseas
sever
strongest
evid
start
within
h
ill
onset
studi
need
clarifi
surviv
benefit
patient
risk
develop
complic
influenza
patient
complic
develop
zanamivir
reserv
patient
immunocompromis
widespread
resist
among
influenza
virus
amantadin
class
drug
amantadin
rimantadin
recommend
current
circul
strain
virus
structur
similar
orthomyxovirida
ssrna
genom
segment
hana
part
glycopeptid
spike
two
separ
spike
envelop
also
contain
fusion
protein
caus
host
cell
form
multinucl
giant
cell
syncytia
paramyxovirida
virus
pathogen
human
parainfluenza
virus
respiratori
syncyti
viru
rsv
human
metapneumoviru
mump
viru
measl
viru
hendra
viru
nipah
viru
newcastl
diseas
viru
hendra
viru
nipah
viru
newcastl
diseas
viru
zoonot
infect
transmit
humantohuman
discuss
respiratori
syncyti
viru
rsv
predominantli
caus
sever
diseas
children
first
year
life
lead
bronchiol
pneumonia
particularli
sever
prematur
children
chronic
lung
diseas
congenit
heart
diseas
neuromuscular
disord
immunodefici
prophylaxi
im
palivizumab
consid
highrisk
individu
adult
popul
reinfect
rsv
usual
caus
mild
selflimit
urt
symptom
flulik
ill
howev
becom
increasingli
recogn
caus
pneumonia
immunocompromis
elderli
particularli
chronic
lung
heart
diseas
resid
longterm
care
facil
rsv
outbreak
commonli
coincid
influenza
pandem
go
undetect
death
attribut
influenza
unless
appropri
laboratori
diagnost
test
use
infect
confirm
detect
viral
genom
rtpcr
urt
lrt
specimen
see
influenza
diagnosi
aerosol
ribavirin
benefit
treat
rsv
infect
immunocompromis
patient
use
immunocompet
approach
support
experi
stem
cell
transplant
popul
treatment
confer
mortal
benefit
may
also
case
cell
immunosuppress
patient
use
ribavirin
usual
recommend
transplant
guidelin
stem
cell
solid
organ
four
type
human
parainfluenza
viru
hpiv
usual
caus
rel
mild
urti
flulik
ill
though
caus
lrti
elderli
children
immunocompromis
commonest
pathogen
caus
croup
paediatr
popul
infect
best
confirm
detect
viral
genom
rtpcr
urt
lrt
specimen
aerosol
ribavirin
may
benefit
treat
hpiv
infect
immunocompromis
patient
use
immunocompet
case
rsv
infect
like
hpiv
human
metapneumoviru
hmpv
usual
caus
rel
mild
urti
flulik
ill
though
caus
lrti
elderli
children
immunocompromis
infect
best
confirm
detect
viral
genom
rt
pcr
urt
lrt
specimen
see
influenza
diagnosi
aerosol
ribavirin
may
benefit
treat
hmpv
infect
immunocompromis
patient
use
immunocompet
viru
replic
urt
local
lymph
node
undergo
haematogen
dissemin
distant
organ
parotid
testicular
swell
commonli
seen
infertil
rare
complic
mening
enceph
occur
necessit
transfer
intens
care
environ
rare
complic
also
includ
sensorineur
hear
loss
pancreat
myocard
thyroid
hepat
nephriti
diagnosi
clinic
ground
may
support
serolog
test
includ
detect
igm
igg
antibodi
though
notori
insensit
confirm
best
achiev
rtpcr
throat
saliva
csf
urin
sampl
treatment
larg
support
outbreak
measl
notifi
diseas
health
protect
regul
common
area
vaccin
rate
low
highli
transmiss
lot
case
occur
contact
index
case
incub
period
week
viral
replic
occur
upper
respiratori
mucu
membran
conjunctiva
commonli
prodrom
ill
fever
malais
anorexia
follow
coryza
cough
conjunct
follow
emerg
koplik
spot
crop
greywhit
lesion
buccal
mucosa
day
later
characterist
maculopapular
rash
like
mump
spread
distant
organ
caus
complic
includ
pneumonia
myocard
enceph
subacut
scleros
panenceph
rare
delay
form
measl
enceph
may
present
sever
year
initi
infect
incoordin
mental
deterior
diagnosi
clinic
ground
alongsid
viral
rtpcr
throat
urin
urtthroat
csf
specimen
serolog
studi
igm
igg
antibodi
necessari
public
health
england
publish
guidanc
use
human
normal
immunoglobulin
use
within
day
exposur
immunosuppress
day
exposur
pregnant
women
infant
year
age
amelior
measl
diseas
support
treatment
antibiot
may
requir
secondari
bacteri
infect
isol
precaut
recommend
tabl
hiv
infect
tlymphocyt
predispos
opportunist
infect
often
lead
icu
admiss
topic
review
previous
dealt
coronavirus
caus
mild
urti
howev
coronavirus
includ
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
receiv
recent
public
virus
caus
lower
respiratori
tract
diseas
high
mortal
transmit
easili
humantohuman
infect
best
confirm
detect
viral
genom
rt
pcr
urt
lrt
specimen
treatment
larg
support
specif
antivir
therapi
adenovirida
doublestrand
nonenvelop
dna
virus
caus
respiratori
particularli
type
gastrointestin
neurolog
eye
infect
immunolog
distinct
type
remark
stabl
hostil
environ
allow
surviv
long
period
outsid
host
spread
primarili
via
droplet
faecoor
rout
infect
individu
shed
diseas
potenti
month
year
symptom
clinic
resolv
respiratori
infect
lead
croup
tonsil
otiti
pneumonia
particularli
sever
children
immunocompromis
nearli
adult
serolog
evid
previou
exposur
adenovirus
caus
hepat
enceph
pneumonia
chronic
lifethreaten
diarrhoea
haemorrhag
cystiti
immunocompromis
diagnosi
achiev
pcr
bal
liver
csf
faecal
sampl
adenovir
load
blood
use
initi
preemptiv
treatment
cidofovir
prevent
adenovir
diseas
heavili
cell
immunosuppress
patient
particularli
children
need
done
weekli
period
patient
risk
develop
lifethreaten
endorgan
diseas
treatment
adenovir
diseas
reduct
immunosuppress
therapi
possibl
treatment
cidofovir
prehydr
coadministr
probenecid
minim
renal
injuri
use
ribavirin
contenti
consist
evid
virolog
respons
vivo
vast
major
primari
infect
hsv
subclin
antibodi
confirm
previou
exposur
adult
clinic
symptom
immunocompet
present
includ
gingivostomat
genit
herp
conjunct
kerat
enceph
sever
dissemin
neonat
hsv
infect
immunocompromis
includ
pneumonia
hepat
coliti
enceph
may
requir
organ
support
hsv
enceph
present
pyrexia
alter
conscious
bizarr
behaviour
disord
mentat
psychiatr
symptom
seizur
local
neurolog
sign
must
consid
potenti
caus
patient
treatabl
aciclovir
typic
csf
analysi
show
clear
appear
high
white
cell
count
lymphocyt
normal
slightli
rais
protein
normal
csf
glucos
plasma
ratio
pcr
hsv
csf
confirm
diagnosi
patient
although
may
neg
first
day
diseas
mortal
around
six
time
higher
immunocompromis
patient
hsv
pneumonia
seen
immunocompromis
patient
best
diagnos
perform
hsv
pcr
lrt
specimen
hsv
particularli
respons
treatment
aciclovir
guanin
analogu
specif
cytotox
hsvinfect
cell
select
part
due
presenc
hsv
thymidin
kinas
infect
cell
activ
aciclovir
monophosphoryl
process
host
cell
thymidin
kinas
perform
viru
caus
chickenpox
children
highli
contagi
approxim
adult
infect
exposur
viru
infect
respiratori
tract
viraemia
follow
headach
malais
characterist
rash
start
face
trunk
spread
centrifug
usual
develop
crop
vesicl
crust
dri
patient
longer
consid
infecti
reactiv
latenc
sensori
ganglia
period
stress
reduc
cellmedi
immun
viral
replic
migrat
along
peripher
nerv
skin
occur
caus
shingl
diagnosi
usual
clinic
confirm
vzv
pcr
vesicular
fluid
vzv
infect
particularli
sever
fetu
neonat
adult
immunocompromis
patient
lead
congenit
varicella
syndrom
neonat
chickenpox
pneumonia
enceph
may
requir
icu
support
uk
guidanc
recommend
pregnant
women
immunocompromis
patient
offer
varicellazosterimmunoglobulin
vzig
within
day
exposur
pool
plasma
product
good
safeti
profil
prophylaxi
oral
valaciclovir
option
vzig
given
g
td
day
first
day
contact
day
treatment
lifethreaten
vzv
infect
dissemin
shingl
iv
aciclovir
oral
valaciclovir
g
td
may
use
uncompl
shingl
chickenpox
day
immunocompromis
continu
h
pass
without
new
vesicl
format
univers
infect
control
precaut
follow
tabl
healthcar
worker
contact
patient
shed
cmv
bodi
fluid
includ
previous
unexpos
pregnant
women
primari
cmv
infect
sometim
lead
congenit
cmv
infect
fetu
viru
infect
human
bcell
commonli
caus
primari
selflimit
ill
infecti
mononucleosi
character
fever
pharyng
headach
malais
lethargi
accompani
lymphadenopathi
splenomegali
rare
mening
enceph
haemolysi
splenic
ruptur
occur
also
predispos
develop
burkitt
lymphoma
nasopharyng
carcinoma
certain
circumst
immunocompromis
posttranspl
popul
ebvdriven
lymphoprolifer
also
known
posttranspl
lymphoprolif
diseas
ptld
occur
diagnosi
infecti
mononucleosi
often
suspect
atyp
mononuclear
cell
found
peripher
blood
film
virolog
diagnosi
confirm
serolog
detect
heterophil
antibodi
ebv
igm
antibodi
antivir
treatment
infecti
mononucleosi
advoc
diseas
usual
selflimit
though
corticosteroid
may
use
case
signific
neurolog
involv
haemolysi
thrombocytopenia
summari
viral
ill
frequent
present
nonspecif
symptom
lead
delay
diagnosi
treatment
primari
present
virallik
symptom
may
also
reflect
opportunist
diseas
immunocompromis
patient
close
liaison
medic
virologist
medic
microbiologist
advis
specimen
collect
investig
interpret
result
antivir
treatment
patient
suspect
viral
ill
viru
detect
immunocompromis
alway
indic
diseas
prompt
investig
diagnosi
antivir
treatment
ill
key
good
outcom
term
morbid
mortal
final
prevent
infect
immun
antivir
prophylaxi
infect
control
equal
import
gener
manag
viral
infect
commun
healthcar
facil
diagnosi
manag
infect
control
precaut
summar
tabl
none
declar
